Asian Ethnicity as a Predictor of Response in Patients with Non–Small-Cell Lung Cancer Treated with Gefitinib on an Expanded Access Program-Reference-Cited by-同舟云学术

Asian Ethnicity as a Predictor of Response in Patients with Non–Small-Cell Lung Cancer Treated with Gefitinib on an Expanded Access Program

Published:2006-03 Issue:5 Volume:7 Page:326-331
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Thomas Sheeba K.,Fossella Frank V.,Liu Diane,Schaerer Rainell,Tsao Anne S.,Kies Merrill S.,Pisters Katherine M.,Blumenschein George R.,Glisson Bonnie S.,Lee J. Jack,Herbst Roy S.,Zinner Ralph G.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference13 articles.

1. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer [published erratum in J Clin Oncol 2004; 22:4811];Fukuoka;J Clin Oncol,2003

2. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial;Kris;JAMA,2003

3. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial–INTACT 1;Giaccone;J Clin Oncol,2004

4. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial–INTACT 2;Herbst;J Clin Oncol,2004

5. Erlotinib in previously treated non-smallcell lung cancer;Shepherd;N Engl J Med,2005

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementation;npj Genomic Medicine;2020-03-05

2. Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome;Integrative Cancer Therapies;2020-01

3. Kinase inhibitors and monoclonal antibodies in oncology: clinical implications;Nature Reviews Clinical Oncology;2015-12-31

4. Inter-ethnic differences in drug response: Implications for drug development and complying with drug regulation;Clinical Research and Regulatory Affairs;2015-07-03

5. Management of Diarrhea Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors;Current Oncology;2014-12-01